HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corinne Chadéneau Selected Research

Prodrugs

12/2011A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
4/2010Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Corinne Chadéneau Research Topics

Disease

7Neoplasms (Cancer)
12/2022 - 11/2008
7Glioblastoma (Glioblastoma Multiforme)
12/2022 - 04/2010
5Neuroblastoma
04/2016 - 02/2004
1Prostatic Neoplasms (Prostate Cancer)
12/2022
1Glioma (Gliomas)
11/2014

Drug/Important Bio-Agent (IBA)

5Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2019 - 02/2004
4NeuropeptidesIBA
01/2019 - 10/2008
4Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
01/2019 - 11/2006
3Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2019 - 10/2008
2cyclopamineIBA
12/2011 - 04/2010
2ProdrugsIBA
12/2011 - 04/2010
2GlucuronidesIBA
12/2011 - 04/2010
1Proteins (Proteins, Gene)FDA Link
12/2022
1Caspase 3 (Caspase-3)IBA
12/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2022
1Mitogen-Activated Protein Kinase 3IBA
12/2022
1eupholIBA
12/2022
1Type I Vasoactive Intestinal Polypeptide ReceptorsIBA
11/2014
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
11/2014
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2008

Therapy/Procedure

3Therapeutics
12/2022 - 11/2008
1Drug Therapy (Chemotherapy)
04/2010